|
C4ORF29 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.83009998453588E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.445640E-04 |
| Normal-vs-Stage2 |
2.870600E-01 |
| Normal-vs-Stage3 |
6.42380038051726E-10 |
| Normal-vs-Stage4 |
2.50080001151787E-09 |
| Stage1-vs-Stage2 |
4.085000E-01 |
| Stage1-vs-Stage3 |
3.102100E-03 |
| Stage1-vs-Stage4 |
4.448000E-04 |
| Stage2-vs-Stage3 |
1.584120E-02 |
| Stage2-vs-Stage4 |
4.099700E-03 |
| Stage3-vs-Stage4 |
3.288200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.87790002729116E-09 |
| Normal-vs-AfricanAmerican |
4.757300E-04 |
| Normal-vs-Asian |
7.583400E-01 |
| Caucasian-vs-AfricanAmerican |
9.767400E-01 |
| Caucasian-vs-Asian |
1.335800E-01 |
| AfricanAmerican-vs-Asian |
9.738500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.18819970424045E-10 |
| Normal-vs-Female |
1.644820E-03 |
| Male-vs-Female |
1.047530E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.883100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.551400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.35349997876233E-09 |
| Normal-vs-Age(81-100Yrs) |
2.282400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.723200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.684200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.284200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.514200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.713400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.900600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.812400E-01 |
| Normal-vs-Grade 2 |
2.079800E-03 |
| Normal-vs-Grade 3 |
1.7504000027202E-08 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
7.095700E-02 |
| Grade 1-vs-Grade 3 |
4.161700E-03 |
| Grade 1-vs-Grade 4 |
2.435800E-03 |
| Grade 2-vs-Grade 3 |
1.852140E-02 |
| Grade 2-vs-Grade 4 |
4.45519954261897E-10 |
| Grade 3-vs-Grade 4 |
1.73187999999991E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.729390E-01 |
| Normal-vs-ccB subtype |
6.08149974823391E-10 |
| ccA subtype-vs-ccB subtype |
1.41119999996775E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.35840000000409E-05 |
| Normal-vs-N1 |
5.372700E-04 |
| N0-vs-N1 |
5.204100E-02 |
|
|
